Bosnia and Herzegovina vs Brazil: Proportion of bloodstream infection due to methicillin-resistant
Bosnia and Herzegovina
28.4%
in 2023
Brazil
27.5%
in 2023
Bosnia and Herzegovina rank
28th
Brazil rank
29th
Proportion of bloodstream infection due to methicillin-resistant over time
- Bosnia and Herzegovina
- Brazil
How they compare
Bosnia and Herzegovina currently reports 28.4% against 27.5% in Brazil, a difference of 0.9%.
The two have swapped places 4 times across 6 shared years of data; in 2018 it was Bosnia and Herzegovina ahead.
Bosnia and Herzegovina ranks 28th and Brazil ranks 29th of 55 countries.
Across the 2 decades both report, Bosnia and Herzegovina averaged higher in 1 and Brazil in 1.
Head to head by decade
| Decade | Bosnia and Herzegovina | Brazil | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 13.4% | 15.8% | 2.4% | Brazil |
| 2020s | 24.8% | 22.6% | 2.1% | Bosnia and Herzegovina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of bloodstream infection due to methicillin-resistant, Bosnia and Herzegovina or Brazil?
- Bosnia and Herzegovina, at 28.4% against 27.5% in Brazil as of 2023.
- What is the difference in proportion of bloodstream infection due to methicillin-resistant between Bosnia and Herzegovina and Brazil?
- 0.9%, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Brazil?
- 6 years are reported by both, from 2018 to 2023.
- How do Bosnia and Herzegovina and Brazil rank globally for proportion of bloodstream infection due to methicillin-resistant?
- Bosnia and Herzegovina ranks 28th and Brazil ranks 29th of 55 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.